Organisme : Société de recherche sur le cancer

  Projets financés à l'Université Laval
    Amino acid neurotransmitter reprogramming of the tumour microenvironment and metabolism in glioblastoma
    Anti-PEG antibodies and adverse reactions to PEGylated drugs: effect of mRNA vaccination and novel mitigation strategies.
    Structural characterization of full-length BET proteins and their functional implications to cancer
    Targeting the prostate cancer metabolic program established upon loss of the KLF5 gene
    The effect of cannabinoid receptors on breast cancer survival
    UGT2B28 IS A PROGNOSTIC AND PREDICTIVE BIOMARKER IN PROSTATE CANCER
    Uncovering the mechanisms of cell adhesion-induced chemoresistance in T cell acute lymphoblastic leukemia (T-ALL)
    Understanding the molecular determinants of high-grade endometrial stromal sarcomas